. abbvie VoyagerTx Launch $1.5B GeneTherapy Collaboration Aimed at Parkinsons Other Synucleinopathies httpow.lyIVmN30nNAv6Âpic.twitter.comrNWnrsgdn5

. @abbvie, @VoyagerTx Launch $1.5B+ #GeneTherapy Collaboration Aimed at #Parkinsons, Other Synucleinopathies: http://ow.ly/IVmN30nNAv6 pic.twitter.com/rNWnrsgdn5

15:25 EST 24 Feb 2019 | Genetic Engineering News

. @abbvie, @VoyagerTx Launch $1.5B+ #GeneTherapy Collaboration Aimed at #Parkinsons, Other Synucleinopathies: http://ow.ly/IVmN30nNAv6 pic.twitter.com/rNWnrsgdn5

More From BioPortfolio on ". @abbvie, @VoyagerTx Launch $1.5B+ #GeneTherapy Collaboration Aimed at #Parkinsons, Other Synucleinopathies: http://ow.ly/IVmN30nNAv6 pic.twitter.com/rNWnrsgdn5"